2010
DOI: 10.2478/v10007-010-0019-6
|View full text |Cite
|
Sign up to set email alerts
|

Impact of superdisintegrants on efavirenz release from tablet formulations

Abstract: EFV is a non-nucleoside reverse transcriptase inhibitor and is used as part of the highly active antiretroviral therapy for the treatment of human immunodeficiency virus type 1 (HIV) infection. It is also used in combination with other antiretroviral agents as part of an expanded post-exposure prophylaxis regimen to prevent HIV transmission for those exposed to materials associated with a high risk of HIV transmission.EFV has poor aqueous solubility and is a BCS class II drug (1). EFV tablets of 600 mg are ava… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 10 publications
0
5
0
1
Order By: Relevance
“…EFV belongs to class II of Biopharmaceutical Classification System (BCS); that is, it is poorly water-soluble and highly permeable [1]. Several approaches to improve efavirenz dissolution are reported, namely the manipulation of polymorphs [1], the use of superdisintegrants [2], solid dispersions [3,4], nano-sized polymeric micelles [5] and complexation with two chemically modified β-cyclodextrins, RAMEB and HPβCD [6].…”
Section: Introductionmentioning
confidence: 99%
“…EFV belongs to class II of Biopharmaceutical Classification System (BCS); that is, it is poorly water-soluble and highly permeable [1]. Several approaches to improve efavirenz dissolution are reported, namely the manipulation of polymorphs [1], the use of superdisintegrants [2], solid dispersions [3,4], nano-sized polymeric micelles [5] and complexation with two chemically modified β-cyclodextrins, RAMEB and HPβCD [6].…”
Section: Introductionmentioning
confidence: 99%
“…A novel HCD, composed of 1% drug (BC), 27% sodium alginate, 2% crospovidone, 8% polyisobutylene, 25% styrene–isoprene–styrene copolymer, 25% petroleum hydrocarbon resin, and 12% liquid paraffin, was prepared using a hot melting method. Sodium alginate, crospovidone, and liquid paraffin were used as a hydrocolloid forming base [Balakrishnan et al, ; Devi et al, ], drug release‐controlling agent [Rajesh et al, ] and plasticizer [Jones et al, ], respectively and polyisobutylene, styrene–isoprene–styrene copolymer and petroleum hydrocarbon resin were used as the pressure‐sensitive adhesives and elastomers [Zohuriaan‐Mehr and Omidian, ]. These materials impart chemical inertness and excellent resistance to weathering, higher temperatures, and chemicals.…”
Section: Resultsmentioning
confidence: 99%
“…Bagian pertama ditambahkan sebelum serbuk dibasahi dengan cairan granulasi (intra) dan sisanya ditambahkan ke granul (ekstra) sebelum tablet dicetak. Mekanisme kerja metode ini yaitu tablet dipecah menjadi granul oleh baian ekstragranular selanjutnya granul terdisintegrasi oleh bagian intragranular untuk melepaskan zat obat ke dalam larutan serta metode ini lebih efektif (Rajesh, et al, 2010).…”
Section: Intra Dan Ekstragranularunclassified